Mindfulness group visit for Breast Cancer

Stanford University, Palo Alto, CA
Targeting 4 different conditionsMindfulness +1 moreN/AWaitlist AvailableLed by Lisa Golman-Rosas, PhDResearch Sponsored by Stanford University

Study Summary

This trial is testing a mindfulness program to see if it can help Latina breast cancer patients with anxiety and depression.

Eligible Conditions
  • Breast Cancer
  • Depression and Anxiety
  • Mindfulness
  • Sleep Disorder

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You have been feeling anxious, sad, or having trouble sleeping for a while.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability change across session
Difference in Feasibility
Secondary outcome measures
Differences in Center for Epidemiological Studies-Depression (CES-D) between time points.
Differences in Generalized Anxiety Disorder-7 (GAD7) between time points.
Differences in PROMIS-SD between time points

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Mindfulness group visitActive Control1 Intervention
Participants will attend 6 weekly educational and mindfulness sessions
Group II: Wait list controlPlacebo Group1 Intervention
Participants will be placed on a wait list

Find a site

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,293 Previous Clinical Trials
17,285,529 Total Patients Enrolled
57 Trials studying Breast Cancer
111,211 Patients Enrolled for Breast Cancer
Maria G Juarez-Reyes, MD, PhDStudy Director
Stanford University
Lisa Golman-Rosas, PhDPrincipal Investigator
Stanford University

Media Library

Mindfulness Clinical Trial Eligibility Overview. Trial Name: NCT04834154 — N/A
Breast Cancer Research Study Groups: Mindfulness group visit, Wait list control
Breast Cancer Clinical Trial 2023: Mindfulness Highlights & Side Effects. Trial Name: NCT04834154 — N/A
Mindfulness 2023 Treatment Timeline for Medical Study. Trial Name: NCT04834154 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for patients to still participate in this clinical investigation?

"As per information on clinicaltrials.gov, the current recruitment period for this trial has ended as of June 21st 2022. Despite it no longer being open to enrollment, 2819 other trials are presently recruiting participants."

Answered by AI
~9 spots leftby Oct 2024